{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:35Z","timestamp":1792788515309,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fasa University of Medical Sciences","award":["403013"],"award-info":[{"award-number":["403013"]}],"id":[{"id":"https:\/\/ror.org\/05bh0zx16","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children. The XRCC6 and XRCC7 genes play a key role in the nonhomologous end-joining (NHEJ) repair process and may influence susceptibility to ALL. The aim of this study is to evaluate the polymorphisms\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G (rs2267437)<\/jats:italic>\n                      and\n                      <jats:italic>XRCC7 6721G\u2009&gt;\u2009T (rs7003908)<\/jats:italic>\n                      in children with ALL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Genomic DNA was extracted from the buffy coat from whole blood samples of patients. Genotyping of\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G<\/jats:italic>\n                      and\n                      <jats:italic>XRCC7 6721G\u2009&gt;\u2009T<\/jats:italic>\n                      polymorphisms was performed by PCR followed by restriction fragment length polymorphism (PCR-RFLP) using specific restriction enzymes (\n                      <jats:italic>BanI<\/jats:italic>\n                      and\n                      <jats:italic>Pvu II<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this investigation significant associations were discovered between\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G<\/jats:italic>\n                      genotypes CC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006) and CG (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) with ALL patients. It is important to note that while the CC genotype association remained significant after Bonferroni correction (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), the CG genotype association was nominal (P between 0.01 and 0.05) and should be interpreted with caution.\n                      <jats:italic>XRCC7 6721G\u2009&gt;\u2009T<\/jats:italic>\n                      genotypes GT (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) and TT (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05) were significantly associated with ALL in males and females, respectively. In ALL patients with B-Cell subtype,\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G<\/jats:italic>\n                      genotypes CC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04), GC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05), and C allele (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05) showed significant associations.\n                      <jats:italic>XRCC7 6721G\u2009&gt;\u2009T<\/jats:italic>\n                      genotypes GT (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) and TT (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05) were also significantly associated in B-Cell ALL. Significant associations were observed for\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G<\/jats:italic>\n                      genotype CC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04) and C allele (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) in ALL patients with favorable cytogenetic abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In conclusion, our findings suggest that the\n                      <jats:italic>XRCC6 -61\u00a0C\u2009&gt;\u2009G<\/jats:italic>\n                      and\n                      <jats:italic>XRCC7 6721G\u2009&gt;\u2009T<\/jats:italic>\n                      polymorphisms may be associated with susceptibility to pediatric ALL, with potential lineage-specific and cytogenetic context-dependent effects. However, given the exploratory nature of our subgroup analyses and the statistical limitations, these results should be interpreted cautiously. Large-scale, multi-center studies with functional validation are needed to confirm these associations and elucidate the underlying mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00402-6","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:48:29Z","timestamp":1792144109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of XRCC6 -61\u00a0C\u2009&gt;\u2009G and XRCC7 6721G\u2009&gt;\u2009T polymorphisms with susceptibility to pediatric acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"38","author":[{"given":"Mani","family":"Ramzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soodabeh","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Noshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Nikfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahed","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyar","family":"Iravani Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"402_CR1","doi-asserted-by":"crossref","unstructured":"Mostafavi A, Saidi MS, Moghtaderi M. Three-dimensional simulation of circulating tumor cells magnetic isolation using a viscoelastic-based ferrofluid solution. J Magn Magn Mater. 2025:172847.","DOI":"10.1016\/j.jmmm.2025.172847"},{"key":"402_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11033-018-4447-6","volume":"46","author":"F Raeisi","year":"2019","unstructured":"Raeisi F, Abolfathi M, Ahmadi-Naji R, Iranparast S, Noshadi E, Akbari A, et al. ARA lncRNA, is upregulated in liver and breast tumor tissues. Mol Biol Rep. 2019;46:77\u201382.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"402_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","volume":"62","author":"D Bhojwani","year":"2015","unstructured":"Bhojwani D, Yang JJ, Pui C-H. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):47.","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"402_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"C-H Pui","year":"1998","unstructured":"Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339(9):605\u201315.","journal-title":"N Engl J Med"},{"issue":"3","key":"402_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.34172\/aim.2021.34","volume":"24","author":"SR Pordanjani","year":"2021","unstructured":"Pordanjani SR, Kavousi A, Mirbagheri B, Shahsavani A, Etemad K. Geographical pathology of acute lymphoblastic leukemia in Iran with evaluation of incidence trends of this disease using joinpoint regression analysis. Arch Iran Med. 2021;24(3):224\u201332.","journal-title":"Arch Iran Med"},{"key":"402_CR6","doi-asserted-by":"crossref","unstructured":"Pui C-H, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. 1993.","DOI":"10.1182\/blood.V82.2.343.343"},{"issue":"7","key":"402_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/leu.2014.30","volume":"28","author":"K Schultz","year":"2014","unstructured":"Schultz K, Carroll A, Heerema N, Bowman W, Aledo A, Slayton W, et al. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031. Leukemia. 2014;28(7):1467\u201371.","journal-title":"Leukemia"},{"issue":"04","key":"402_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0042-1742593","volume":"11","author":"MI Saadi","year":"2022","unstructured":"Saadi MI, Tahmasebijaroubi F, Noshadi E, Rahimikian R, Karimi Z, Owjfard M, et al. Dysregulated expression of miR-19b, miR-25, miR-17, WT1, and CEBPA in patients with acute myeloid leukemia and association with graft versus host disease after hematopoietic stem cell transplantation. South Asian J Cancer. 2022;11(04):346\u201352.","journal-title":"South Asian J Cancer"},{"key":"402_CR9","doi-asserted-by":"publisher","first-page":"e2394","DOI":"10.31661\/gmj.v11i.2394","volume":"11","author":"A Khalafi-Nezhad","year":"2022","unstructured":"Khalafi-Nezhad A, Saadi MI, Noshadi N, Jalali H, Ahmadyan M, Kheradmand N, et al. Change in Programmed Death-1 and Inducible Costimulator Expression in Patients with Acute Myeloid Leukemia Following Chemotherapy and Its Cytogenetic Abnormalities. Galen Med J. 2022;11:e2394\u2013e.","journal-title":"Galen Med J"},{"issue":"3","key":"402_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","volume":"109","author":"KR Schultz","year":"2007","unstructured":"Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, et al. Risk-and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children\u2019s Cancer Group (CCG). Blood. 2007;109(3):926\u201335.","journal-title":"Blood"},{"key":"402_CR11","doi-asserted-by":"crossref","unstructured":"Saadi MI, Hosseini F, Rostamipour HA, Jamhiri I, Noshadi N, Tabrizi R et al. Investigating Apoptotic Effect through Blocking miR-181b and miR-222 Using LNA-anti-miRNA in HL-60 Cell Line: Strategies to Improve Hematopoietic Stem Cell Transplantation. Int J Organ Transpl Med (IJOTM). 2024;15(1).","DOI":"10.61186\/ijotm.2024.15.1148"},{"issue":"1","key":"402_CR12","doi-asserted-by":"publisher","first-page":"e2014073","DOI":"10.4084\/mjhid.2014.073","volume":"6","author":"S Chiaretti","year":"2014","unstructured":"Chiaretti S, Zini G, Bassan R. Diagnosis and subclassification of acute lymphoblastic leukemia. Mediterranean J Hematol Infect Dis. 2014;6(1):e2014073.","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"9","key":"402_CR13","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/cancers13092256","volume":"13","author":"CK Tebbi","year":"2021","unstructured":"Tebbi CK. Etiology of acute leukemia: A review. Cancers. 2021;13(9):2256.","journal-title":"Cancers"},{"issue":"4","key":"402_CR14","first-page":"405","volume":"25","author":"J Du","year":"2013","unstructured":"Du J, Lu C, Cui G, Chen Y, He J. DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis. Chin J Cancer Res. 2013;25(4):405.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"402_CR15","first-page":"389","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG. The molecular genetic makeup of acute lymphoblastic leukemia. Hematol 2010 Am Soc Hematol Educ Program Book. 2012;2012(1):389\u201396.","journal-title":"Hematol 2010 Am Soc Hematol Educ Program Book"},{"issue":"2","key":"402_CR16","first-page":"206","volume":"115","author":"AV Moorman","year":"2010","unstructured":"Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood J Am Soc Hematol. 2010;115(2):206\u201314.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2\u20133","key":"402_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mrrev.2006.09.001","volume":"613","author":"AS Kim","year":"2006","unstructured":"Kim AS, Eastmond DA, Preston RJ. Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures. Mutat Research\/Reviews Mutat Res. 2006;613(2\u20133):138\u201360.","journal-title":"Mutat Research\/Reviews Mutat Res"},{"issue":"1","key":"402_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","volume":"79","author":"MR Lieber","year":"2010","unstructured":"Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79(1):181\u2013211.","journal-title":"Annu Rev Biochem"},{"key":"402_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmolb.2020.00024","volume":"7","author":"AC V\u00edtor","year":"2020","unstructured":"V\u00edtor AC, Huertas P, Legube G, De Almeida SF. Studying DNA double-strand break repair: an ever-growing toolbox. Front Mol Biosci. 2020;7:24.","journal-title":"Front Mol Biosci"},{"issue":"23","key":"402_CR20","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1128\/MCB.00785-07","volume":"27","author":"H Li","year":"2007","unstructured":"Li H, Vogel H, Holcomb VB, Gu Y, Hasty P. Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol Cell Biol. 2007;27(23):8205\u201314.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"402_CR21","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1002\/mco2.388","volume":"4","author":"J Tan","year":"2023","unstructured":"Tan J, Sun X, Zhao H, Guan H, Gao S, Zhou PK. Double-strand DNA break repair: molecular mechanisms and therapeutic targets. MedComm. 2023;4(5):e388.","journal-title":"MedComm"},{"issue":"2","key":"402_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.21873\/cgp.20436","volume":"21","author":"C-C Chen","year":"2024","unstructured":"Chen C-C, Chang W-S, Pei J-S, Kuo C-C, Wang C-H, Wang Y-C, et al. Non-homologous end-joining genotype, mRNA expression, and DNA repair capacity in childhood acute lymphocytic leukemia. Cancer Genomics Proteomics. 2024;21(2):144\u201357.","journal-title":"Cancer Genomics Proteomics"},{"issue":"12","key":"402_CR23","first-page":"5395","volume":"33","author":"J-S Pei","year":"2013","unstructured":"Pei J-S, Lee Y-M, Lo H-H, Hsu Y-N, Lin S-S, Bau D-T. Association of X-ray repair cross-complementing-6 genotypes with childhood leukemia. Anticancer Res. 2013;33(12):5395\u20139.","journal-title":"Anticancer Res"},{"issue":"5","key":"402_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1089\/dna.2014.2465","volume":"34","author":"D Jahantigh","year":"2015","unstructured":"Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M, Narooei-nejad M, et al. Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol. 2015;34(5):360\u20136.","journal-title":"DNA Cell Biol"},{"issue":"2","key":"402_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4149\/av_2019_210","volume":"63","author":"M Ramzi","year":"2019","unstructured":"Ramzi M, Arandi N, Zarei T, Saadi MI, Yaghobi R, Moghadam M, et al. Genetic variation of TNF-\u03b1 and IL-10, IL-12, IL-17 genes and association with torque teno virus infection post hematopoietic stem cell transplantation. Acta Virol. 2019;63(2):186\u201394.","journal-title":"Acta Virol"},{"issue":"4","key":"402_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/08820139.2013.879594","volume":"43","author":"M Iravani-Saadi","year":"2014","unstructured":"Iravani-Saadi M, Karimi MH, Yaghobi R, Geramizadeh B, Ramzi M, Niknam A, et al. Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients. Immunol Investig. 2014;43(4):391\u2013404.","journal-title":"Immunol Investig"},{"issue":"12","key":"402_CR27","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.leukres.2006.01.016","volume":"30","author":"P Bolufer","year":"2006","unstructured":"Bolufer P, Barragan E, Collado M, Cervera J, L\u00f3pez J-A, Sanz MA. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res. 2006;30(12):1471\u201391.","journal-title":"Leuk Res"},{"issue":"1\u20132","key":"402_CR28","first-page":"201","volume":"509","author":"JG de Boer","year":"2002","unstructured":"de Boer JG. Polymorphisms in DNA repair and environmental interactions. Mutat Research\/Fundamental Mol Mech Mutagen. 2002;509(1\u20132):201\u201310.","journal-title":"Mutat Research\/Fundamental Mol Mech Mutagen"},{"issue":"3","key":"402_CR29","first-page":"802","volume":"8","author":"M Krajinovic","year":"2002","unstructured":"Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res. 2002;8(3):802\u201310.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"402_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12967-023-04447-2","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Peng Q, Zhang B, Tan Y. X-ray cross-complementing family: the bridge linking DNA damage repair and cancer. J Translational Med. 2023;21(1):602.","journal-title":"J Translational Med"},{"issue":"10","key":"402_CR31","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.31557\/APJCP.2022.23.10.3577","volume":"23","author":"S Aref","year":"2022","unstructured":"Aref S, El Menshawy N, Abou Zeid T, Gouda E, Aziz NA. DNA repair genes polymorphisms: impact on acute myeloid leukemia patients outcome. Asian Pac J Cancer Prevention: APJCP. 2022;23(10):3577.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"6","key":"402_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.55730\/1300-0144.5902","volume":"54","author":"E Akg\u00fcn","year":"2024","unstructured":"Akg\u00fcn E, Mutlu Icduygu F, \u015eeng\u00fcl D, Alp E, Alkanat M, CEB\u0130 A, et al. Association between papillary thyroid cancer and XRCC6 gene polymorphisms in the Turkish population. Turk J Med Sci. 2024;54(6):1215\u201322.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"402_CR33","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1097\/MD.0000000000000283","volume":"94","author":"J Jia","year":"2015","unstructured":"Jia J, Ren J, Yan D, Xiao L, Sun R. Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis. Medicine. 2015;94(1):e283.","journal-title":"Medicine"},{"issue":"1","key":"402_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41021-021-00176-4","volume":"43","author":"S Shelke","year":"2021","unstructured":"Shelke S, Das B. Radio-adaptive response and correlation of non-homologous end joining repair gene polymorphisms [XRRC5 (3R\/2R\/1R\/0R), XRCC6 (C\/G) and XRCC7 (G\/T)] in human peripheral blood mononuclear cells exposed to gamma radiation. Genes Environ. 2021;43(1):9.","journal-title":"Genes Environ"},{"issue":"1","key":"402_CR35","first-page":"4795076","volume":"2017","author":"D Jahantigh","year":"2017","unstructured":"Jahantigh D, Hosseinzadeh Colagar A. XRCC5 VNTR, XRCC6-61C\u2009>\u2009G, and XRCC7 6721G\u2009>\u2009T gene polymorphisms associated with male infertility risk: evidences from case\u2010control and in silico studies. Int J Endocrinol. 2017;2017(1):4795076.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"402_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/ijms.4799","volume":"9","author":"Y Zhi","year":"2012","unstructured":"Zhi Y, Yu J, Liu Y, Wei Q, Yuan F, Zhou X, et al. Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int J Med Sci. 2012;9(6):498.","journal-title":"Int J Med Sci"},{"issue":"5","key":"402_CR37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.31557\/APJCP.2025.26.5.1571","volume":"26","author":"MN Patil","year":"2025","unstructured":"Patil MN, Bhandurge PJ, Kadam SS, Datkhile KD. Sequence Variation in X-ray Cross Complimenting (XRCC4, XRCC5, XRCC6 and XRCC7) Genes and the Risk of Gastrointestinal Cancer in South-Western Maharashtra: A Hospital Based Case-Control Study. Asian Pac J Cancer Prev. 2025;26(5):1571\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"402_CR38","first-page":"2453","volume":"6","author":"KD Datkhile","year":"2018","unstructured":"Datkhile KD, Patil MN, Durgawale PP, Korabu KS, Joshi SA, Kakade SV. Association of genetic polymorphisms in XRCC4, XRCC5, XRCC6 and XRCC7 in cervical cancer susceptibility from rural population: a hospital based case-control study. Int J. 2018;6(7):2453.","journal-title":"Int J"},{"issue":"25","key":"402_CR39","doi-asserted-by":"publisher","first-page":"20599","DOI":"10.1007\/s11356-017-9701-2","volume":"24","author":"Y Aftabi","year":"2017","unstructured":"Aftabi Y, Hosseinzadeh Colagar A, Mehrnejad F, Seyedrezazadeh E, Moudi E. Aryl hydrocarbon receptor gene transitions (c.-742C\u2009>\u2009T; c. 1661G\u2009>\u2009A) and idiopathic male infertility: a case-control study with in silico and meta-analysis. Environ Sci Pollut Res. 2017;24(25):20599\u2013615.","journal-title":"Environ Sci Pollut Res"},{"issue":"12","key":"402_CR40","first-page":"7001","volume":"34","author":"T-C Hsia","year":"2014","unstructured":"Hsia T-C, Chang W-S, Chen W-C, Liang S-J, Tu C-Y, Chen H-J, et al. Genotype of DNA double-strand break repair gene XRCC7 is associated with lung cancer risk in Taiwan males and smokers. Anticancer Res. 2014;34(12):7001\u20135.","journal-title":"Anticancer Res"},{"issue":"02","key":"402_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-0043-1771213","volume":"12","author":"D Choudhary","year":"2023","unstructured":"Choudhary D, Mahajan B, Sumi M, Dholakia B, Bhandari S, Ghimire N, et al. Polymorphism of XRCC7 gene and risk of Glioma: A prospective case\u2013control study. Indian J Neurosurg. 2023;12(02):168\u201373.","journal-title":"Indian J Neurosurg"},{"key":"402_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-020-00061-9","volume":"21","author":"F Farokhian","year":"2020","unstructured":"Farokhian F, Beyzaei Z, Ramzi M, Geramizadeh B. Association between genetic polymorphism of XRCC7 (G6721T) and risk of acute lymphoblastic leukemia. Egypt J Med Hum Genet. 2020;21:1\u20134.","journal-title":"Egypt J Med Hum Genet"},{"issue":"144","key":"402_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.30699\/jambs.31.144.46","volume":"31","author":"Z Karimi Moghaddam","year":"2023","unstructured":"Karimi Moghaddam Z, Karimkhanilouei S, Asaadi Tehrani G. Association between Polymorphisms of X-ray Repair Cross Complementing 5 and 6 Promoter Genes and the Risk of Metastatic Breast Cancer. J Adv Med Biomedical Res. 2023;31(144):46\u201356.","journal-title":"J Adv Med Biomedical Res"},{"issue":"9","key":"402_CR44","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1158\/1055-9965.EPI-10-0389","volume":"19","author":"JS Chang","year":"2010","unstructured":"Chang JS, Wiemels JL, Chokkalingam AP, Metayer C, Barcellos LF, Hansen HM, et al. Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2152\u201363.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"402_CR45","unstructured":"Karimi MZ, Ekrami B, Asaadi TG. Association between Polymorphisms of X-ray Repair Cross Complementing 5 and 6 Promoter Genes and the Risk of Metastatic Breast Cancer. 2023."}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00402-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:48:31Z","timestamp":1792144111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00402-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00402-6","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical ConsiderationsAll the patients signed the written informed consent by the Helsinki protocol of 1975, and the study was approved by the Ethical Committee of Shiraz University of Medical Sciences (IR.FUMS.REC.1403.107). The study was conducted following informed consent obtained from patients or their legal parents.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"78"}}